Subject: Fw: [EXT] WHO information note on the "Solidarity" trial
From: Tamar Gabunia </O=EXCHORGANIZATION/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=E6CA04F38EC94D0CADAB9CBDF90FCDDE-TAMAR G>
To: info </o=ExchOrganization/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=2069f7f4886b493dbd84f07150d67a52-info>
Cc: Maia Nikoleishvili </o=ExchOrganization/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=2d9c4ecc95234453ad52ccfeaee8a8ee-Maia Ni>
Date: Sat, 04 Apr 2020 18:04:31 +0000

​გთხოვთ დაარეგისტრიროთ

From: MAMULASHVILI, Nino <[email-masked]>

Sent: Friday, April 3, 2020 9:31 PM

To: Tamar Gabunia

Subject: FW: [EXT] WHO information note on the "Solidarity" trial

Dear Dr Gabunia,

As a follow up of communication with you related to SOLIDARITY Trial, please find email from Dr Masoud Dara, Coordinator, Communicable Diseases, Division of Health Emergencies & Communicable Diseases, WHO
EURO.

Looking forward to receiving feedback from you.

Thank you in advance.

Kind regards,

Nino

From: DARA, Masoud

Sent: Friday, April 3, 2020 21:15

To: EURO2019nCoV <[email-masked]>

Cc: PFEIFER, Dina <[email-masked]>; GASIMOV, Elkhan <[email-masked]>; EURO DEC/JTH CO P Staff <[email-masked]>; HUMBERT, Tifenn Lucile Marie <[email-masked]>; STETSYK, Vitalii <[email-masked]>; PIRGARI, Dorina <[email-masked]>;
KOROTYCH, Oleksandr <[email-masked]>; SHARMA, Tarang <[email-masked]>; EURO Strategic Relations with Countries <[email-masked]>; KEÇIK, Melda <[email-masked]>; KULI, Arta <[email-masked]>; EURO DEC/JTH RO P Staff <[email-masked]>

Subject: FW: [EXT] WHO information note on the "Solidarity" trial

Respectful WRs/HWOs (in bcc),

Dear colleagues,

FYI and sharing with MoHs,

All the best,

Masoud

From: [email-masked] <[email-masked]>
On Behalf Of STEWART, Saira

Sent: Friday, April 3, 2020 6:34 PM

To: [email-masked]

Subject: [EXT] WHO information note on the "Solidarity" trial

Dear colleagues,

WHO has just published an information note on “Solidarity,” an international clinical trial launched by WHO and partners aimed at finding an effective treatment for COVID-19. The note includes some strong language
around the use of chloroquine and hydroxychloroquine in the context of COVID-19:

“Until there is sufficient evidence, WHO cautions against physicians and medical associations recommending or administering these unproven treatments to patients with COVID-19 or people self-medicating with them. WHO is concerned
by reports of individuals self-medicating with chloroquine and causing themselves serious harm.”

The full information note can be found at:
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments.

Best wishes,

Saira

Saira Stewart

Global
Malaria Programme

t:
+ 41 22 791 4217
e: [email-masked]

m:
+41 79 500 6538
www.who.int/malaria

ABOUT THE WHO MALARIA LISTSERV

This message was sent to you through a global mailing list for WHO technical staff working on malaria. The list is moderated by the Global Malaria Programme at WHO Headquarters. If you wish to send a message to all WHO malaria staff, please address it to
[email-masked]. The moderator will release your message to all recipients as soon as possible. Feel free to add links or attachments. If you wish to subscribe or unsubscribe from this mailing list, please
send a message to [email-masked].